Hematology/Oncology

Catalog description

The hematology oncology module will include an integrated approach combining anatomy & physiology, biochemistry, medicinal chemistry, pharmacology, pathology & pathophysiology, pharmacotherapeutics, clinical pharmacokinetics, and pharmacogenetics of the hematological disorders and oncology. Concepts from medicinal chemistry will be coupled with the pharmacology of the drugs involved in this module. This will include chemical features of therapeutic agents required to elicit biological response and their role in affecting physiochemical properties. Pharmacology principles will include drug receptor interactions and subsequent biological responses, biochemical mechanisms of drug action, adverse and toxic effects, contraindications, and important drug-drug interactions. The pathophysiology and therapeutic principles in clinical practice will be incorporated in a sequential and integrative manner. This will enable students to relate knowledge from both basic sciences and clinical sciences. Clinical pharmacokinetic concepts will also be included with application of basic biopharmaceutical and pharmacokinetic concepts to clinical management of various patients’ conditions in order to provide safe and effective therapy. Relevant pharmacogenetic considerations that may impact safety or efficacy of therapeutic agents and the role of pharmacogenetics in the clinical decision-making process and making therapeutic recommendations will also be discussed. Concepts of complementary and alternative medicine will also be discussed as they relate to the hematology oncology module.